Want to join the conversation?
$LLY's revenue by product had mixed results YoverY as Forteo, Strattera, Trajenta, and Animal Health revenues increased YoverY while Alimta, Humulin, Cymbalta, Zyprexa, and Evista reported declines in revenue; Evista declined significantly by 35%. On a YoverY basis, Humalog, Cialis, and Effient reported flat revenues compared to last year.
What are your expectations from $COKE tomorrow?? Will the bear attack the beverage?
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.